James Chodosh Selected Research

Adenoviridae Infections (Adenovirus Infections)

1/2021	Adenovirus and the Cornea: More Than Meets the Eye.
1/2017	Role of MyD88 in adenovirus keratitis.
10/2016	Protein Kinase C Signaling in Adenoviral Infection.
9/2015	Novel model of innate immunity in corneal infection.
4/2010	Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis.
10/2005	Corneal cell survival in adenovirus type 19 infection requires phosphoinositide 3-kinase/Akt activation.
6/2003	Corneal IL-8 expression following adenovirus infection is mediated by c-Src activation in human corneal fibroblasts.
8/2002	Activation of focal adhesion kinase in adenovirus-infected human corneal fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James Chodosh Research Topics

Disease

30	Infections 01/2022 - 05/2002
25	Keratitis 01/2022 - 05/2002
17	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2021 - 08/2010
17	Inflammation (Inflammations) 01/2021 - 05/2002
12	Glaucoma 09/2022 - 04/2007
8	Adenoviridae Infections (Adenovirus Infections) 01/2021 - 08/2002
8	Burns 01/2020 - 01/2013
7	Wounds and Injuries (Trauma) 11/2021 - 01/2019
5	Blindness (Hysterical Blindness) 01/2022 - 04/2012
4	COVID-19 01/2022 - 01/2020
4	Neoplasms (Cancer) 10/2021 - 04/2005
4	Limbal Stem Cell Deficiency 01/2021 - 10/2016
4	Virus Diseases (Viral Diseases) 01/2013 - 01/2002
3	Endophthalmitis (Ophthalmia) 12/2020 - 07/2016
3	Ganglion Cysts (Ganglion) 10/2020 - 04/2007
3	Ulcer 06/2020 - 08/2002
3	Chemical Burns (Chemical Burn) 02/2018 - 12/2015
2	Cataract (Cataracts) 09/2022 - 01/2021
2	Edema (Dropsy) 09/2022 - 03/2013
2	Conjunctivitis 01/2022 - 10/2020
2	Coinfection 01/2022 - 01/2018
2	Cicatrix (Scar) 01/2021 - 01/2020
2	Mycoses (Diseases, Fungus) 01/2021 - 07/2016
2	Keratoconus 01/2021 - 03/2013
2	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2021 - 01/2019
2	Corneal Injuries 01/2020 - 01/2013
2	Tissue Adhesions 01/2020 - 04/2016
2	Autoimmune Diseases (Autoimmune Disease) 06/2017 - 07/2016
2	Pneumonia (Pneumonitis) 11/2016 - 08/2002
2	Bullous Pemphigoid (Pemphigoid) 07/2013 - 08/2010
2	Corneal Neovascularization 06/2013 - 01/2013
2	Eye Infections 09/2006 - 09/2003
2	Rosacea (Acne Rosacea) 12/2004 - 01/2004
1	Ocular Hypertension (Glaucoma, Suspect) 09/2022
1	Diabetes Mellitus 03/2022
1	Chronic Disease (Chronic Diseases) 01/2021
1	Acanthamoeba Keratitis 01/2021
1	Disease Progression 01/2021
1	Meibomian Gland Dysfunction 01/2021

Drug/Important Bio-Agent (IBA)

10	ChemokinesIBA 09/2015 - 01/2002
9	Retinaldehyde (Retinal)IBA 03/2022 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2002
8	CytokinesIBA 10/2020 - 01/2006
6	AlkaliesIBA 01/2020 - 01/2013
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 07/2007
5	Matrix Metalloproteinases (MMPs)IBA 07/2016 - 12/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 06/2003
4	Messenger RNA (mRNA)IBA 10/2020 - 06/2003
4	Interleukin-8 (Interleukin 8)IBA 12/2009 - 06/2003
3	VaccinesIBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 11/2021 - 01/2004
3	AcidsIBA 03/2019 - 05/2014
3	Peroxidase (Myeloperoxidase)IBA 01/2016 - 02/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 06/2003
3	Small Interfering RNA (siRNA)IBA 01/2013 - 01/2008
3	Mitogen-Activated Protein KinasesIBA 07/2012 - 10/2005
2	Ophthalmic Solutions (Eye Drops)IBA 09/2022 - 09/2016
2	SteroidsIBA 03/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2007
2	Biological ProductsIBA 11/2021 - 05/2002
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 12/2019
2	Interleukin-6 (Interleukin 6)IBA 10/2020 - 01/2006
2	Polymethyl Methacrylate (Sol)IBA 01/2020 - 04/2016
2	Povidone-Iodine (Betadine)FDA LinkGeneric 11/2019 - 07/2016
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2019 - 06/2017
2	Monoclonal AntibodiesIBA 06/2017 - 09/2003
2	Viral DNAIBA 01/2017 - 04/2010
2	Caveolin 1IBA 10/2016 - 01/2013
2	src-Family KinasesIBA 09/2015 - 01/2013
2	p38 Mitogen-Activated Protein KinasesIBA 09/2015 - 01/2008
2	Phosphotransferases (Kinase)IBA 01/2013 - 06/2003
2	BuffersIBA 05/2012 - 02/2007
2	IntegrinsIBA 04/2010 - 08/2002
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2009 - 10/2005
2	InterferonsIBA 08/2008 - 07/2007
2	Tyrosine (L-Tyrosine)FDA Link 06/2003 - 08/2002
1	netarsudilIBA 09/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	HydrogelsIBA 11/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Complement C5 (Complement 5)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	miltefosine (Impavido)IBA 01/2021
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021
1	Local Anti-Infective Agents (Antiseptics)IBA 12/2020

Therapy/Procedure

16	Therapeutics 01/2022 - 09/2004
9	Transplantation 01/2022 - 01/2016
5	Corneal Transplantation (Keratoplasty) 10/2021 - 01/2013
4	Penetrating Keratoplasty 01/2021 - 03/2013
3	Sutures (Suture) 01/2021 - 03/2013
2	Contact Lenses 07/2016 - 04/2016
2	Lasers (Laser) 09/2014 - 07/2011
1	Tissue Transplantation 11/2021
1	Refractive Surgical Procedures 01/2021
1	Lenses 01/2021
1	Salvage Therapy 01/2021